Enli Liu, David Marin, Pinaki Banerjee, Homer A Macapinlac, Philip Thompson, Rafet Basar, Lucila Nassif Kerbauy, Bethany Overman, Peter Thall, Mecit Kaplan, Vandana Nandivada, Indresh Kaur, Ana Nunez Cortes, Kai Cao, May Daher, Chitra Hosing, Evan N Cohen, Partow Kebriaei, Rohtesh Mehta, Sattva Neelapu, Yago Nieto, Michael Wang, William Wierda, Michael Keating, Richard Champlin, Elizabeth J Shpall, Katayoun Rezvani. N Engl J Med 2020
Times Cited: 630
Times Cited: 630
Times Cited
Times Co-cited
Similarity
Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity.
E Liu, Y Tong, G Dotti, H Shaim, B Savoldo, M Mukherjee, J Orange, X Wan, X Lu, A Reynolds,[...]. Leukemia 2018
E Liu, Y Tong, G Dotti, H Shaim, B Savoldo, M Mukherjee, J Orange, X Wan, X Lu, A Reynolds,[...]. Leukemia 2018
26
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.
Shannon L Maude, Theodore W Laetsch, Jochen Buechner, Susana Rives, Michael Boyer, Henrique Bittencourt, Peter Bader, Michael R Verneris, Heather E Stefanski, Gary D Myers,[...]. N Engl J Med 2018
Shannon L Maude, Theodore W Laetsch, Jochen Buechner, Susana Rives, Michael Boyer, Henrique Bittencourt, Peter Bader, Michael R Verneris, Heather E Stefanski, Gary D Myers,[...]. N Engl J Med 2018
24
Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity.
Ye Li, David L Hermanson, Branden S Moriarity, Dan S Kaufman. Cell Stem Cell 2018
Ye Li, David L Hermanson, Branden S Moriarity, Dan S Kaufman. Cell Stem Cell 2018
20
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.
Jeffrey S Miller, Yvette Soignier, Angela Panoskaltsis-Mortari, Sarah A McNearney, Gong H Yun, Susan K Fautsch, David McKenna, Chap Le, Todd E Defor, Linda J Burns,[...]. Blood 2005
Jeffrey S Miller, Yvette Soignier, Angela Panoskaltsis-Mortari, Sarah A McNearney, Gong H Yun, Susan K Fautsch, David McKenna, Chap Le, Todd E Defor, Linda J Burns,[...]. Blood 2005
20
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.
Sattva S Neelapu, Frederick L Locke, Nancy L Bartlett, Lazaros J Lekakis, David B Miklos, Caron A Jacobson, Ira Braunschweig, Olalekan O Oluwole, Tanya Siddiqi, Yi Lin,[...]. N Engl J Med 2017
Sattva S Neelapu, Frederick L Locke, Nancy L Bartlett, Lazaros J Lekakis, David B Miklos, Caron A Jacobson, Ira Braunschweig, Olalekan O Oluwole, Tanya Siddiqi, Yi Lin,[...]. N Engl J Med 2017
19
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia.
Rizwan Romee, Maximillian Rosario, Melissa M Berrien-Elliott, Julia A Wagner, Brea A Jewell, Timothy Schappe, Jeffrey W Leong, Sara Abdel-Latif, Stephanie E Schneider, Sarah Willey,[...]. Sci Transl Med 2016
Rizwan Romee, Maximillian Rosario, Melissa M Berrien-Elliott, Julia A Wagner, Brea A Jewell, Timothy Schappe, Jeffrey W Leong, Sara Abdel-Latif, Stephanie E Schneider, Sarah Willey,[...]. Sci Transl Med 2016
19
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.
Loredana Ruggeri, Marusca Capanni, Elena Urbani, Katia Perruccio, Warren D Shlomchik, Antonella Tosti, Sabrina Posati, Daniela Rogaia, Francesco Frassoni, Franco Aversa,[...]. Science 2002
Loredana Ruggeri, Marusca Capanni, Elena Urbani, Katia Perruccio, Warren D Shlomchik, Antonella Tosti, Sabrina Posati, Daniela Rogaia, Francesco Frassoni, Franco Aversa,[...]. Science 2002
17
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Stephen J Schuster, Michael R Bishop, Constantine S Tam, Edmund K Waller, Peter Borchmann, Joseph P McGuirk, Ulrich Jäger, Samantha Jaglowski, Charalambos Andreadis, Jason R Westin,[...]. N Engl J Med 2019
Stephen J Schuster, Michael R Bishop, Constantine S Tam, Edmund K Waller, Peter Borchmann, Joseph P McGuirk, Ulrich Jäger, Samantha Jaglowski, Charalambos Andreadis, Jason R Westin,[...]. N Engl J Med 2019
17
NK cells for cancer immunotherapy.
Noriko Shimasaki, Amit Jain, Dario Campana. Nat Rev Drug Discov 2020
Noriko Shimasaki, Amit Jain, Dario Campana. Nat Rev Drug Discov 2020
17
Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells.
Chihaya Imai, Shotaro Iwamoto, Dario Campana. Blood 2005
Chihaya Imai, Shotaro Iwamoto, Dario Campana. Blood 2005
15
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study.
Jeremy S Abramson, M Lia Palomba, Leo I Gordon, Matthew A Lunning, Michael Wang, Jon Arnason, Amitkumar Mehta, Enkhtsetseg Purev, David G Maloney, Charalambos Andreadis,[...]. Lancet 2020
Jeremy S Abramson, M Lia Palomba, Leo I Gordon, Matthew A Lunning, Michael Wang, Jon Arnason, Amitkumar Mehta, Enkhtsetseg Purev, David G Maloney, Charalambos Andreadis,[...]. Lancet 2020
15
CAR-NK cells: A promising cellular immunotherapy for cancer.
Guozhu Xie, Han Dong, Yong Liang, James Dongjoo Ham, Romee Rizwan, Jianzhu Chen. EBioMedicine 2020
Guozhu Xie, Han Dong, Yong Liang, James Dongjoo Ham, Romee Rizwan, Jianzhu Chen. EBioMedicine 2020
14
Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells.
Cecele J Denman, Vladimir V Senyukov, Srinivas S Somanchi, Prasad V Phatarpekar, Lisa M Kopp, Jennifer L Johnson, Harjeet Singh, Lenka Hurton, Sourindra N Maiti, M Helen Huls,[...]. PLoS One 2012
Cecele J Denman, Vladimir V Senyukov, Srinivas S Somanchi, Prasad V Phatarpekar, Lisa M Kopp, Jennifer L Johnson, Harjeet Singh, Lenka Hurton, Sourindra N Maiti, M Helen Huls,[...]. PLoS One 2012
14
Exploring the NK cell platform for cancer immunotherapy.
Jacob A Myers, Jeffrey S Miller. Nat Rev Clin Oncol 2021
Jacob A Myers, Jeffrey S Miller. Nat Rev Clin Oncol 2021
14
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia.
Jae H Park, Isabelle Rivière, Mithat Gonen, Xiuyan Wang, Brigitte Sénéchal, Kevin J Curran, Craig Sauter, Yongzeng Wang, Bianca Santomasso, Elena Mead,[...]. N Engl J Med 2018
Jae H Park, Isabelle Rivière, Mithat Gonen, Xiuyan Wang, Brigitte Sénéchal, Kevin J Curran, Craig Sauter, Yongzeng Wang, Bianca Santomasso, Elena Mead,[...]. N Engl J Med 2018
13
Expansion of highly cytotoxic human natural killer cells for cancer cell therapy.
Hiroyuki Fujisaki, Harumi Kakuda, Noriko Shimasaki, Chihaya Imai, Jing Ma, Timothy Lockey, Paul Eldridge, Wing H Leung, Dario Campana. Cancer Res 2009
Hiroyuki Fujisaki, Harumi Kakuda, Noriko Shimasaki, Chihaya Imai, Jing Ma, Timothy Lockey, Paul Eldridge, Wing H Leung, Dario Campana. Cancer Res 2009
13
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells.
May Daher, Rafet Basar, Elif Gokdemir, Natalia Baran, Nadima Uprety, Ana Karen Nunez Cortes, Mayela Mendt, Lucila Nassif Kerbauy, Pinaki P Banerjee, Mayra Shanley,[...]. Blood 2021
May Daher, Rafet Basar, Elif Gokdemir, Natalia Baran, Nadima Uprety, Ana Karen Nunez Cortes, Mayela Mendt, Lucila Nassif Kerbauy, Pinaki P Banerjee, Mayra Shanley,[...]. Blood 2021
18
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial.
Frederick L Locke, Armin Ghobadi, Caron A Jacobson, David B Miklos, Lazaros J Lekakis, Olalekan O Oluwole, Yi Lin, Ira Braunschweig, Brian T Hill, John M Timmerman,[...]. Lancet Oncol 2019
Frederick L Locke, Armin Ghobadi, Caron A Jacobson, David B Miklos, Lazaros J Lekakis, Olalekan O Oluwole, Yi Lin, Ira Braunschweig, Brian T Hill, John M Timmerman,[...]. Lancet Oncol 2019
11
CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas.
Margery Gang, Nancy D Marin, Pamela Wong, Carly C Neal, Lynne Marsala, Mark Foster, Timothy Schappe, Wei Meng, Jennifer Tran, Maximilian Schaettler,[...]. Blood 2020
Margery Gang, Nancy D Marin, Pamela Wong, Carly C Neal, Lynne Marsala, Mark Foster, Timothy Schappe, Wei Meng, Jennifer Tran, Maximilian Schaettler,[...]. Blood 2020
21
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma.
Michael Wang, Javier Munoz, Andre Goy, Frederick L Locke, Caron A Jacobson, Brian T Hill, John M Timmerman, Houston Holmes, Samantha Jaglowski, Ian W Flinn,[...]. N Engl J Med 2020
Michael Wang, Javier Munoz, Andre Goy, Frederick L Locke, Caron A Jacobson, Brian T Hill, John M Timmerman, Houston Holmes, Samantha Jaglowski, Ian W Flinn,[...]. N Engl J Med 2020
11
Human chimeric antigen receptor macrophages for cancer immunotherapy.
Michael Klichinsky, Marco Ruella, Olga Shestova, Xueqing Maggie Lu, Andrew Best, Martha Zeeman, Maggie Schmierer, Konrad Gabrusiewicz, Nicholas R Anderson, Nicholas E Petty,[...]. Nat Biotechnol 2020
Michael Klichinsky, Marco Ruella, Olga Shestova, Xueqing Maggie Lu, Andrew Best, Martha Zeeman, Maggie Schmierer, Konrad Gabrusiewicz, Nicholas R Anderson, Nicholas E Petty,[...]. Nat Biotechnol 2020
11
First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia.
Xiaowen Tang, Lin Yang, Zheng Li, Ansel P Nalin, Haiping Dai, Ting Xu, Jia Yin, Fengtao You, Mingqing Zhu, Wenhong Shen,[...]. Am J Cancer Res 2018
Xiaowen Tang, Lin Yang, Zheng Li, Ansel P Nalin, Haiping Dai, Ting Xu, Jia Yin, Fengtao You, Mingqing Zhu, Wenhong Shen,[...]. Am J Cancer Res 2018
10
Adoptive Transfer of NKG2D CAR mRNA-Engineered Natural Killer Cells in Colorectal Cancer Patients.
Lin Xiao, Dongzhi Cen, Haining Gan, Yan Sun, Nanqi Huang, Hanzhen Xiong, Qiongmei Jin, Liqun Su, Xuejuan Liu, Kejian Wang,[...]. Mol Ther 2019
Lin Xiao, Dongzhi Cen, Haining Gan, Yan Sun, Nanqi Huang, Hanzhen Xiong, Qiongmei Jin, Liqun Su, Xuejuan Liu, Kejian Wang,[...]. Mol Ther 2019
13
CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma.
J Chu, Y Deng, D M Benson, S He, T Hughes, J Zhang, Y Peng, H Mao, L Yi, K Ghoshal,[...]. Leukemia 2014
J Chu, Y Deng, D M Benson, S He, T Hughes, J Zhang, Y Peng, H Mao, L Yi, K Ghoshal,[...]. Leukemia 2014
10
Targeting natural killer cells in cancer immunotherapy.
Camille Guillerey, Nicholas D Huntington, Mark J Smyth. Nat Immunol 2016
Camille Guillerey, Nicholas D Huntington, Mark J Smyth. Nat Immunol 2016
10
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells.
Pascale André, Caroline Denis, Caroline Soulas, Clarisse Bourbon-Caillet, Julie Lopez, Thomas Arnoux, Mathieu Bléry, Cécile Bonnafous, Laurent Gauthier, Ariane Morel,[...]. Cell 2018
Pascale André, Caroline Denis, Caroline Soulas, Clarisse Bourbon-Caillet, Julie Lopez, Thomas Arnoux, Mathieu Bléry, Cécile Bonnafous, Laurent Gauthier, Ariane Morel,[...]. Cell 2018
10
IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function.
Daniel A Vallera, Martin Felices, Ron McElmurry, Valarie McCullar, Xianzheng Zhou, Joerg Uwe Schmohl, Bin Zhang, Alexander J Lenvik, Angela Panoskaltsis-Mortari, Michael R Verneris,[...]. Clin Cancer Res 2016
Daniel A Vallera, Martin Felices, Ron McElmurry, Valarie McCullar, Xianzheng Zhou, Joerg Uwe Schmohl, Bin Zhang, Alexander J Lenvik, Angela Panoskaltsis-Mortari, Michael R Verneris,[...]. Clin Cancer Res 2016
10
CIS is a potent checkpoint in NK cell-mediated tumor immunity.
Rebecca B Delconte, Tatiana B Kolesnik, Laura F Dagley, Jai Rautela, Wei Shi, Eva M Putz, Kimberley Stannard, Jian-Guo Zhang, Charis Teh, Matt Firth,[...]. Nat Immunol 2016
Rebecca B Delconte, Tatiana B Kolesnik, Laura F Dagley, Jai Rautela, Wei Shi, Eva M Putz, Kimberley Stannard, Jian-Guo Zhang, Charis Teh, Matt Firth,[...]. Nat Immunol 2016
10
Cytokine activation induces human memory-like NK cells.
Rizwan Romee, Stephanie E Schneider, Jeffrey W Leong, Julie M Chase, Catherine R Keppel, Ryan P Sullivan, Megan A Cooper, Todd A Fehniger. Blood 2012
Rizwan Romee, Stephanie E Schneider, Jeffrey W Leong, Julie M Chase, Catherine R Keppel, Ryan P Sullivan, Megan A Cooper, Todd A Fehniger. Blood 2012
10
Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation.
Stefan O Ciurea, Jolie R Schafer, Roland Bassett, Cecele J Denman, Kai Cao, Dana Willis, Gabriela Rondon, Julianne Chen, Doris Soebbing, Indreshpal Kaur,[...]. Blood 2017
Stefan O Ciurea, Jolie R Schafer, Roland Bassett, Cecele J Denman, Kai Cao, Dana Willis, Gabriela Rondon, Julianne Chen, Doris Soebbing, Indreshpal Kaur,[...]. Blood 2017
10
Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity.
Huang Zhu, Robert H Blum, Davide Bernareggi, Eivind Heggernes Ask, Zhengming Wu, Hanna Julie Hoel, Zhipeng Meng, Chengsheng Wu, Kun-Liang Guan, Karl-Johan Malmberg,[...]. Cell Stem Cell 2020
Huang Zhu, Robert H Blum, Davide Bernareggi, Eivind Heggernes Ask, Zhengming Wu, Hanna Julie Hoel, Zhipeng Meng, Chengsheng Wu, Kun-Liang Guan, Karl-Johan Malmberg,[...]. Cell Stem Cell 2020
15
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial.
Daniel W Lee, James N Kochenderfer, Maryalice Stetler-Stevenson, Yongzhi K Cui, Cindy Delbrook, Steven A Feldman, Terry J Fry, Rimas Orentas, Marianna Sabatino, Nirali N Shah,[...]. Lancet 2015
Daniel W Lee, James N Kochenderfer, Maryalice Stetler-Stevenson, Yongzhi K Cui, Cindy Delbrook, Steven A Feldman, Terry J Fry, Rimas Orentas, Marianna Sabatino, Nirali N Shah,[...]. Lancet 2015
9
Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.
Marco L Davila, Isabelle Riviere, Xiuyan Wang, Shirley Bartido, Jae Park, Kevin Curran, Stephen S Chung, Jolanta Stefanski, Oriana Borquez-Ojeda, Malgorzata Olszewska,[...]. Sci Transl Med 2014
Marco L Davila, Isabelle Riviere, Xiuyan Wang, Shirley Bartido, Jae Park, Kevin Curran, Stephen S Chung, Jolanta Stefanski, Oriana Borquez-Ojeda, Malgorzata Olszewska,[...]. Sci Transl Med 2014
9
Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells.
Zeguo Zhao, Maud Condomines, Sjoukje J C van der Stegen, Fabiana Perna, Christopher C Kloss, Gertrude Gunset, Jason Plotkin, Michel Sadelain. Cancer Cell 2015
Zeguo Zhao, Maud Condomines, Sjoukje J C van der Stegen, Fabiana Perna, Christopher C Kloss, Gertrude Gunset, Jason Plotkin, Michel Sadelain. Cancer Cell 2015
9
'Off-the-shelf' allogeneic CAR T cells: development and challenges.
S Depil, P Duchateau, S A Grupp, G Mufti, L Poirot. Nat Rev Drug Discov 2020
S Depil, P Duchateau, S A Grupp, G Mufti, L Poirot. Nat Rev Drug Discov 2020
9
CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells.
Jianfeng Han, Jianhong Chu, Wing Keung Chan, Jianying Zhang, Youwei Wang, Justus B Cohen, Aaron Victor, Walter H Meisen, Sung-Hak Kim, Paola Grandi,[...]. Sci Rep 2015
Jianfeng Han, Jianhong Chu, Wing Keung Chan, Jianying Zhang, Youwei Wang, Justus B Cohen, Aaron Victor, Walter H Meisen, Sung-Hak Kim, Paola Grandi,[...]. Sci Rep 2015
9
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation.
Rizwan Romee, Sarah Cooley, Melissa M Berrien-Elliott, Peter Westervelt, Michael R Verneris, John E Wagner, Daniel J Weisdorf, Bruce R Blazar, Celalettin Ustun, Todd E DeFor,[...]. Blood 2018
Rizwan Romee, Sarah Cooley, Melissa M Berrien-Elliott, Peter Westervelt, Michael R Verneris, John E Wagner, Daniel J Weisdorf, Bruce R Blazar, Celalettin Ustun, Todd E DeFor,[...]. Blood 2018
9
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma.
Nikhil C Munshi, Larry D Anderson, Nina Shah, Deepu Madduri, Jesús Berdeja, Sagar Lonial, Noopur Raje, Yi Lin, David Siegel, Albert Oriol,[...]. N Engl J Med 2021
Nikhil C Munshi, Larry D Anderson, Nina Shah, Deepu Madduri, Jesús Berdeja, Sagar Lonial, Noopur Raje, Yi Lin, David Siegel, Albert Oriol,[...]. N Engl J Med 2021
9
Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure.
Jordan Gauthier, Alexandre V Hirayama, Janaki Purushe, Kevin A Hay, James Lymp, Daniel H Li, Cecilia C S Yeung, Alyssa Sheih, Barbara S Pender, Reed M Hawkins,[...]. Blood 2020
Jordan Gauthier, Alexandre V Hirayama, Janaki Purushe, Kevin A Hay, James Lymp, Daniel H Li, Cecilia C S Yeung, Alyssa Sheih, Barbara S Pender, Reed M Hawkins,[...]. Blood 2020
9
The Broad Spectrum of Human Natural Killer Cell Diversity.
Aharon G Freud, Bethany L Mundy-Bosse, Jianhua Yu, Michael A Caligiuri. Immunity 2017
Aharon G Freud, Bethany L Mundy-Bosse, Jianhua Yu, Michael A Caligiuri. Immunity 2017
9
CRISPR-engineered T cells in patients with refractory cancer.
Edward A Stadtmauer, Joseph A Fraietta, Megan M Davis, Adam D Cohen, Kristy L Weber, Eric Lancaster, Patricia A Mangan, Irina Kulikovskaya, Minnal Gupta, Fang Chen,[...]. Science 2020
Edward A Stadtmauer, Joseph A Fraietta, Megan M Davis, Adam D Cohen, Kristy L Weber, Eric Lancaster, Patricia A Mangan, Irina Kulikovskaya, Minnal Gupta, Fang Chen,[...]. Science 2020
9
Cytokine-induced memory-like natural killer cells.
Megan A Cooper, Julie M Elliott, Peter A Keyel, Liping Yang, Javier A Carrero, Wayne M Yokoyama. Proc Natl Acad Sci U S A 2009
Megan A Cooper, Julie M Elliott, Peter A Keyel, Liping Yang, Javier A Carrero, Wayne M Yokoyama. Proc Natl Acad Sci U S A 2009
9
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy.
Emily J Pomeroy, John T Hunzeker, Mitchell G Kluesner, Walker S Lahr, Branden A Smeester, Margaret R Crosby, Cara-Lin Lonetree, Kenta Yamamoto, Laura Bendzick, Jeffrey S Miller,[...]. Mol Ther 2020
Emily J Pomeroy, John T Hunzeker, Mitchell G Kluesner, Walker S Lahr, Branden A Smeester, Margaret R Crosby, Cara-Lin Lonetree, Kenta Yamamoto, Laura Bendzick, Jeffrey S Miller,[...]. Mol Ther 2020
14
Chimeric antigen receptor T cells for sustained remissions in leukemia.
Shannon L Maude, Noelle Frey, Pamela A Shaw, Richard Aplenc, David M Barrett, Nancy J Bunin, Anne Chew, Vanessa E Gonzalez, Zhaohui Zheng, Simon F Lacey,[...]. N Engl J Med 2014
Shannon L Maude, Noelle Frey, Pamela A Shaw, Richard Aplenc, David M Barrett, Nancy J Bunin, Anne Chew, Vanessa E Gonzalez, Zhaohui Zheng, Simon F Lacey,[...]. N Engl J Med 2014
8
Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas.
Stephen J Schuster, Jakub Svoboda, Elise A Chong, Sunita D Nasta, Anthony R Mato, Özlem Anak, Jennifer L Brogdon, Iulian Pruteanu-Malinici, Vijay Bhoj, Daniel Landsburg,[...]. N Engl J Med 2017
Stephen J Schuster, Jakub Svoboda, Elise A Chong, Sunita D Nasta, Anthony R Mato, Özlem Anak, Jennifer L Brogdon, Iulian Pruteanu-Malinici, Vijay Bhoj, Daniel Landsburg,[...]. N Engl J Med 2017
8
Transfection of chimeric anti-CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells.
Hua Jiang, Wenhao Zhang, Peipei Shang, Hui Zhang, Weijun Fu, Fei Ye, Tianmei Zeng, Hejing Huang, Xueguang Zhang, Wanping Sun,[...]. Mol Oncol 2014
Hua Jiang, Wenhao Zhang, Peipei Shang, Hui Zhang, Weijun Fu, Fei Ye, Tianmei Zeng, Hejing Huang, Xueguang Zhang, Wanping Sun,[...]. Mol Oncol 2014
8
Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma.
Nadja Müller, Susanne Michen, Stefanie Tietze, Katrin Töpfer, Alexander Schulte, Katrin Lamszus, Marc Schmitz, Gabriele Schackert, Ira Pastan, Achim Temme. J Immunother 2015
Nadja Müller, Susanne Michen, Stefanie Tietze, Katrin Töpfer, Alexander Schulte, Katrin Lamszus, Marc Schmitz, Gabriele Schackert, Ira Pastan, Achim Temme. J Immunother 2015
8
Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia.
C Quintarelli, S Sivori, S Caruso, S Carlomagno, M Falco, I Boffa, D Orlando, M Guercio, Z Abbaszadeh, M Sinibaldi,[...]. Leukemia 2020
C Quintarelli, S Sivori, S Caruso, S Carlomagno, M Falco, I Boffa, D Orlando, M Guercio, Z Abbaszadeh, M Sinibaldi,[...]. Leukemia 2020
19
DAP12-based activating chimeric antigen receptor for NK cell tumor immunotherapy.
Katrin Töpfer, Marc Cartellieri, Susanne Michen, Ralf Wiedemuth, Nadja Müller, Dirk Lindemann, Michael Bachmann, Monika Füssel, Gabriele Schackert, Achim Temme. J Immunol 2015
Katrin Töpfer, Marc Cartellieri, Susanne Michen, Ralf Wiedemuth, Nadja Müller, Dirk Lindemann, Michael Bachmann, Monika Füssel, Gabriele Schackert, Achim Temme. J Immunol 2015
8
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.